Low-Molecular-Weight Heparins in the Cardiac Catheterization Laboratory
AUTOR(ES)
Kadakia, Rajan A.
RESUMO
We describe the unique properties of low-molecular-weight heparins and review studies of the use of these agents in the catheterization laboratory for percutaneous coronary intervention. Recent data regarding bedside monitoring of low-molecular-weight heparin activity are also discussed, as are ongoing and future studies that should be of assistance to clinicians as they consider expanding the use of this newer form of antithrombotic therapy.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=387437Documentos Relacionados
- Low-molecular-weight heparins in the treatment of venous thromboembolism
- New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins
- Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes
- LOW-MOLECULAR-WEIGHT RHEUMATOID FACTOR*
- Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins
